Treatment Options for Episodic vs Chronic Migraine
For acute treatment of migraine, combination therapy of a triptan with an NSAID or acetaminophen is recommended as first-line treatment for moderate to severe episodic migraine, while chronic migraine requires preventive therapy in addition to acute treatment strategies. 1
Definitions and Classification
- Episodic migraine is defined as headaches occurring on fewer than 15 days per month 2
- Chronic migraine is defined as headaches occurring on at least 15 days per month for at least 3 months, with migraine features on at least 8 days per month 2
- Patients can progress from episodic to chronic migraine over time, with medication overuse being a significant risk factor 3
Acute Treatment Options for Episodic Migraine
First-Line Treatment
- For mild episodic migraine: NSAIDs (aspirin, celecoxib, diclofenac, ibuprofen, naproxen) or acetaminophen monotherapy 1
- For moderate to severe episodic migraine: Combination therapy of a triptan (sumatriptan, rizatriptan, etc.) with an NSAID or acetaminophen 1
- Treatment should begin as soon as possible after headache onset to maximize efficacy 1
Second-Line Treatment
- For patients who don't respond to or cannot tolerate first-line treatments, consider CGRP antagonists-gepants (rimegepant, ubrogepant, zavegepant) 1, 4
- Dihydroergotamine (DHE) can be considered for patients with inadequate response to first-line treatments 1, 4
- Lasmiditan (ditan) should be reserved for patients who don't tolerate or have inadequate response to all other pharmacologic treatments 1, 4
Important Cautions
- Opioids and butalbital-containing medications should not be used for migraine treatment 1, 5
- Be aware of medication overuse headache risk (≥15 days/month with NSAIDs; ≥10 days/month with triptans) 1
- For patients with severe nausea or vomiting, consider non-oral formulations (such as intranasal triptans) and add an antiemetic 1, 4
Treatment for Chronic Migraine
Preventive Treatment
- Preventive therapy is required for all patients with chronic migraine 2, 3
- First-line preventive options include beta-blockers (metoprolol, propranolol), antiseizure medication valproate, SNRIs (venlafaxine), or TCAs (amitriptyline) 1
- CGRP antagonists-gepants (atogepant, rimegepant) or CGRP monoclonal antibodies (eptinezumab, erenumab, fremanezumab, galcanezumab) are effective preventive options 1
- Consider ACE inhibitors (lisinopril), ARBs (candesartan, telmisartan), or SSRIs (fluoxetine) if first-line treatments are not tolerated or ineffective 1
Acute Treatment
- Patients with chronic migraine still require acute treatment for breakthrough headaches, following the same principles as for episodic migraine 1
- Be particularly vigilant about medication overuse, which can worsen chronic migraine 1, 3
Treatment Algorithm for Both Types
- For mild attacks: Start with NSAIDs or acetaminophen 1
- For moderate to severe attacks: Use combination therapy of a triptan with an NSAID or acetaminophen 1
- For inadequate response: Consider CGRP antagonists-gepants or dihydroergotamine 1, 4
- As last resort: Try lasmiditan for patients who don't respond to other treatments 1, 4
- For chronic migraine: Add preventive therapy while managing acute attacks 1, 3
Lifestyle Modifications for Both Types
- Stay well hydrated and maintain regular meals 1, 5
- Ensure sufficient and consistent sleep patterns 1
- Engage in regular physical activity, preferably moderate to intense aerobic exercise 1
- Manage stress with relaxation techniques or mindfulness practices 1, 4
- Pursue weight loss if overweight or obese 1
- Identify and avoid personal migraine triggers 1, 5
Special Considerations
- In women of childbearing potential and those who are pregnant or breastfeeding, discuss the adverse effects of treatments during pregnancy and lactation 1, 4
- Consider using a headache diary to track frequency, severity, triggers, and treatment response 1
- If episodic migraine occurs frequently or treatment doesn't provide adequate response, consider adding preventive medications 1
- Preventive treatment should be initiated at a low dose and gradually increased until desired outcomes are achieved 1